Epigenetic regulation of macrophage polarization and function

Trends in Immunology

Volumn 34, Issue 5, 2013, Pages 216-223

  Ivashkiv, Lionel B ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Chromatin; Epigenetics; Macrophage; Signaling; Transcription

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 1; INTERLEUKIN 12; OSTEOCLAST DIFFERENTIATION FACTOR; SMAD PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR;

COMMENSAL; CPG ISLAND; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; GENE INDUCTION; GENE LOCUS; GENE REPRESSION; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE PHOSPHORYLATION; HOST RESISTANCE; HUMAN; MACROPHAGE ACTIVATION; MICROFLORA; NUCLEAR REPROGRAMMING; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TRANSCRIPTION ELONGATION; TRANSCRIPTION INITIATION SITE;

ANIMALS; CELL DIFFERENTIATION; CELL POLARITY; CELL TRANSDIFFERENTIATION; CYTOKINES; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNITY, CELLULAR; IMMUNOMODULATION; MACROPHAGES; SIGNAL TRANSDUCTION;

EID: 84877119701     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2012.11.001     Document Type: Review

References (84)

1. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011, 11:723-737.
2. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
3. Lawrence T., Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 2011, 11:750-761.
4. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
5. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 2012, 122:787-795.
6. Glass C.K., Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat. Rev. Immunol. 2010, 10:365-376.
7. Medzhitov R., Horng T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 2009, 9:692-703.
8. Smale S.T. Selective transcription in response to an inflammatory stimulus. Cell 2010, 140:833-844.
9. Natoli G., et al. The genomic landscapes of inflammation. Genes Dev. 2011, 25:101-106.
10. Murray P.J., Wynn T.A. Obstacles and opportunities for understanding macrophage polarization. J. Leukoc. Biol. 2011, 89:557-563.
11. Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 2008, 8:533-544.
12. Hume D.A., MacDonald K.P. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 2012, 119:1810-1820.
13. Kobayashi T., et al. IL-10 Regulates Il12b Expression via histone deacetylation: implications for intestinal macrophage homeostasis. J. Immunol. 2012, 189:1792-1799.
14. Wu D., et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332:243-247.
15. Nguyen K.D., et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 2011, 480:104-108.
16. Ivashkiv L.B. Cross-regulation of signaling by ITAM-associated receptors. Nat. Immunol. 2009, 10:340-347.
17. Abt M.C., et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012, 37:158-170.
18. Ganal S.C., et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012, 37:171-186.
19. Bethunaickan R., et al. A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis. J. Immunol. 2011, 186:4994-5003.
20. Hamilton J.A., Tak P.P. The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum. 2009, 60:1210-1221.
21. Hu X., et al. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 2008, 226:41-56.
22. Ivashkiv L.B. Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Eur. J. Immunol. 2011, 41:2477-2481.
23. Pello O.M., et al. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology. Blood 2012, 119:411-421.
24. Xu H., et al. Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization. Nat. Immunol. 2012, 13:642-650.
25. Adelman K., et al. Immediate mediators of the inflammatory response are poised for gene activation through RNA polymerase II stalling. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:18207-18212.
26. Barish G.D., et al. Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response. Genes Dev. 2010, 24:2760-2765.
27. De Santa F., et al. Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J. 2009, 28:3341-3352.
28. Escoubet-Lozach L., et al. Mechanisms establishing TLR4-responsive activation states of inflammatory response genes. PLoS Genet. 2011, 7:e1002401.
29. Hargreaves D.C., et al. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 2009, 138:129-145.
30. Levy D., et al. Lysine methylation of the NF-kappaB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-kappaB signaling. Nat. Immunol. 2011, 12:29-36.
31. Ramirez-Carrozzi V.R., et al. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 2009, 138:114-128.
32. Ramirez-Carrozzi V.R., et al. Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response. Genes Dev. 2006, 20:282-296.
33. Stender J.D., et al. Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20. Mol. Cell 2012, 48:28-38.
34. Chen X., et al. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:16768-16769.
35. Chen J., Ivashkiv L.B. IFN-gamma abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:19438-19443.
36. Foster S.L., et al. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007, 447:972-978.
37. Liu T.F., et al. NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J. Biol. Chem. 2011, 286:9856-9864.
38. Park S.H., et al. Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages. Nat. Immunol. 2012, 12:607-615.
39. Wen H., et al. Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response. Blood 2008, 111:1797-1804.
40. Ishii M., et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 2009, 114:3244-3254.
41. Mullican S.E., et al. Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev. 2011, 25:2480-2488.
42. Satoh T., et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 2010, 11:936-944.
43. Yasui T., et al. Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1. J. Bone Miner. Res. 2011, 26:2665-2671.
44. Natoli G. Maintaining cell identity through global control of genomic organization. Immunity 2010, 33:12-24.
45. Ernst J., et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011, 473:43-49.
46. Margueron R., Reinberg D. Chromatin structure and the inheritance of epigenetic information. Nat. Rev. Genet. 2010, 11:285-296.
47. Mattick J.S. RNA driving the epigenetic bus. EMBO J. 2012, 31:515-516.
48. Mattick J.S., et al. A global view of genomic information - moving beyond the gene and the master regulator. Trends Genet. 2009, 26:21-28.
49. Zhou V.W., et al. Charting histone modifications and the functional organization of mammalian genomes. Nat. Rev. Genet. 2011, 12:7-18.
50. Buecker C., Wysocka J. Enhancers as information integration hubs in development: lessons from genomics. Trends Genet. 2012, 28:276-284.
51. Ghisletti S., et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 2010, 32:317-328.
52. Heinz S., et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 2010, 38:576-589.
53. Jin F., et al. PU.1 and C/EBP(alpha) synergistically program distinct response to NF-kappaB activation through establishing monocyte specific enhancers. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5290-5295.
54. Pham T.H., et al. Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. Blood 2012, 119:e161-e171.
55. Garber M., et al. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol. Cell 2012, 47:810-822.
56. Fang T.C., et al. Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response. J. Exp. Med. 2012, 209:661-669.
57. van Essen D., et al. A feed-forward circuit controlling inducible NF-kappaB target gene activation by promoter histone demethylation. Mol. Cell 2010, 39:750-760.
58. Zhu Y., et al. Cell-type-specific control of enhancer activity by H3K9 trimethylation. Mol. Cell 2012, 46:408-423.
59. Kruidenier L., et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 2012, 488:404-408.
60. De Santa F., et al. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol. 2010, 8:e1000384.
61. Nicodeme E., et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010, 468:1119-1123.
62. Delmore J.E., et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011, 146:904-917.
63. Schenk T., et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat. Med. 2012, 18:605-611.
64. Shakespear M.R., et al. Histone deacetylases as regulators of inflammation and immunity. Trends Immunol. 2011, 32:335-343.
65. Vojinovic J., et al. Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2011, 63:1452-1458.
66. Chinenov Y., et al. Role of transcriptional coregulator GRIP1 in the anti-inflammatory actions of glucocorticoids. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:11776-11781.
67. Gilchrist M., et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 2006, 441:173-178.
68. Hu X., et al. Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways. Immunity 2008, 29:691-703.
69. Saijo K., et al. An ADIOL-ERbeta-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 2011, 145:584-595.
70. Yan Q., et al. Nuclear factor-kappaB binding motifs specify Toll-like receptor-induced gene repression through an inducible repressosome. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:14140-14145.
71. Roger T., et al. Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 2011, 117:1205-1217.
72. Shimizu-Hirota R., et al. MT1-MMP regulates the PI3Kdelta.Mi-2/NuRD-dependent control of macrophage immune function. Genes Dev. 2012, 26:395-413.
73. Hu X., Ivashkiv L.B. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 2009, 31:539-550.
74. Gough D.J., et al. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 2012, 36:166-174.
75. Marazzi I., et al. Suppression of the antiviral response by an influenza histone mimic. Nature 2012, 483:428-433.
76. Yarilina A., et al. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat. Immunol. 2008, 9:378-387.
77. Wang Z., et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 2009, 138:1019-1031.
78. Chi T. A BAF-centred view of the immune system. Nat. Rev. Immunol. 2004, 4:965-977.
79. Ho P.C., et al. NF-kappaB-mediated degradation of the coactivator RIP140 regulates inflammatory responses and contributes to endotoxin tolerance. Nat. Immunol. 2012, 13:379-386.
80. Stout R.D., et al. Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages. J. Leukoc. Biol. 2009, 86:1105-1109.
81. Schroder K., et al. Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E944-E953.
82. Adrianto I., et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat. Genet. 2011, 43:253-258.
83. Bernstein B.E., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
84. Maurano M.T., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.